Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Biotech Industry Analysis
UpdatedApr 12, 2026
DataAggregated Company Financials
Companies34
- 7D2.2%
- 3M8.9%
- 1Y12.5%
- YTD13.6%
In the last week, the Biotech industry is up 2.2%, with SanBio up 7.6%. During this same period, the Innovacell underperformed, falling 8.3%. This means that the industry has gained 13% over the past year. As for the next few years, earnings are expected to grow by 39% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 12 Apr 2026 | JP¥1.2t | JP¥202.7b | -JP¥49,292,644,682.00 | 61.5x | -23.4x | 5.7x |
| Tue, 10 Mar 2026 | JP¥1.2t | JP¥200.5b | -JP¥50,589,800,682.00 | 309.4x | -24.6x | 6.2x |
| Thu, 05 Feb 2026 | JP¥1.1t | JP¥198.6b | -JP¥70,466,747,000.00 | 57.9x | -15.4x | 5.4x |
| Sat, 03 Jan 2026 | JP¥998.4b | JP¥198.7b | -JP¥70,727,387,000.00 | 52.7x | -14.1x | 5x |
| Mon, 01 Dec 2025 | JP¥1.1t | JP¥196.3b | -JP¥69,178,659,000.00 | 52.8x | -15.9x | 5.6x |
| Wed, 29 Oct 2025 | JP¥1.1t | JP¥197.7b | -JP¥65,502,224,000.00 | 63.2x | -17.1x | 5.7x |
| Fri, 26 Sep 2025 | JP¥1.2t | JP¥197.7b | -JP¥65,794,561,000.00 | 66x | -17.7x | 5.9x |
| Sun, 24 Aug 2025 | JP¥1.2t | JP¥193.5b | -JP¥68,135,862,000.00 | 131.9x | -17.2x | 6.1x |
| Tue, 22 Jul 2025 | JP¥1.1t | JP¥218.2b | -JP¥43,758,567,000.00 | 100.8x | -25.4x | 5.1x |
| Thu, 19 Jun 2025 | JP¥1.2t | JP¥218.3b | -JP¥42,833,263,000.00 | 102x | -28.2x | 5.5x |
| Sat, 17 May 2025 | JP¥1.1t | JP¥209.9b | -JP¥37,783,371,000.00 | 15.3x | -28.3x | 5.1x |
| Mon, 14 Apr 2025 | JP¥971.6b | JP¥207.7b | -JP¥39,339,028,000.00 | 13.9x | -24.7x | 4.7x |
| Wed, 12 Mar 2025 | JP¥978.1b | JP¥207.4b | -JP¥38,725,942,000.00 | 15x | -25.3x | 4.7x |
| Fri, 07 Feb 2025 | JP¥1.0t | JP¥207.3b | -JP¥13,596,922,000.00 | 21.1x | -74x | 4.9x |
| Sun, 05 Jan 2025 | JP¥1.1t | JP¥207.3b | -JP¥13,531,081,000.00 | 22.3x | -80.1x | 5.2x |
| Tue, 03 Dec 2024 | JP¥1.1t | JP¥207.2b | -JP¥12,080,899,000.00 | 22.7x | -92.8x | 5.4x |
| Thu, 31 Oct 2024 | JP¥1.1t | JP¥214.3b | -JP¥3,941,502,000.00 | 22.6x | -279.5x | 5.1x |
| Sat, 28 Sep 2024 | JP¥1.1t | JP¥214.3b | -JP¥2,078,229,000.00 | 22x | -552.8x | 5.4x |
| Mon, 26 Aug 2024 | JP¥1.0t | JP¥210.1b | -JP¥580,439,000.00 | 14.2x | -1768.1x | 4.9x |
| Wed, 24 Jul 2024 | JP¥1.1t | JP¥187.7b | -JP¥15,871,901,000.00 | 93.8x | -66.7x | 5.6x |
| Fri, 21 Jun 2024 | JP¥904.7b | JP¥187.7b | -JP¥15,773,284,000.00 | 82.7x | -57.4x | 4.8x |
| Sun, 19 May 2024 | JP¥769.6b | JP¥194.2b | -JP¥14,975,545,000.00 | 93.1x | -51.4x | 4x |
| Tue, 16 Apr 2024 | JP¥738.7b | JP¥194.2b | -JP¥15,746,837,000.00 | 65.1x | -46.9x | 3.8x |
| Thu, 14 Mar 2024 | JP¥776.8b | JP¥193.6b | -JP¥19,603,997,000.00 | 60.1x | -39.6x | 4x |
| Sat, 10 Feb 2024 | JP¥747.3b | JP¥222.4b | -JP¥12,442,827,000.00 | 16.7x | -60.1x | 3.4x |
| Mon, 08 Jan 2024 | JP¥802.9b | JP¥222.3b | -JP¥12,668,455,000.00 | 17.4x | -63.4x | 3.6x |
| Wed, 06 Dec 2023 | JP¥779.0b | JP¥221.9b | -JP¥12,426,487,000.00 | 16.6x | -62.7x | 3.5x |
| Fri, 03 Nov 2023 | JP¥746.6b | JP¥223.0b | -JP¥14,350,085,000.00 | 19.3x | -52x | 3.3x |
| Sun, 01 Oct 2023 | JP¥847.8b | JP¥223.0b | -JP¥14,518,735,000.00 | 26.2x | -58.4x | 3.8x |
| Tue, 29 Aug 2023 | JP¥910.1b | JP¥225.1b | -JP¥19,814,131,000.00 | 49.6x | -45.9x | 4x |
| Thu, 27 Jul 2023 | JP¥918.9b | JP¥223.7b | -JP¥20,836,669,000.00 | 49.1x | -44.1x | 4.1x |
| Sat, 24 Jun 2023 | JP¥973.0b | JP¥223.2b | -JP¥20,139,670,000.00 | 64.6x | -48.3x | 4.4x |
| Mon, 22 May 2023 | JP¥915.5b | JP¥218.6b | -JP¥25,244,669,000.00 | 32.1x | -36.3x | 4.2x |
| Wed, 19 Apr 2023 | JP¥959.7b | JP¥218.3b | -JP¥21,583,522,000.00 | 21.9x | -44.5x | 4.4x |
Price to Earnings Ratio
-44.5x
Current Industry PE
- Investors are optimistic on the Japanese Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 2.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 2.88% | |
| Healthcare | -0.48% | |
| Biotech | 2.25% | |
| Biotech | 2.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4592 SanBio | JP¥1.99k | 7.6% +JP¥10.9b | 10.0% | PB11.4x | |
| 7777 3-D Matrix | JP¥487.00 | 13.0% +JP¥7.0b | 309.2% | PE48.8x | |
| 4588 Oncolys BioPharma | JP¥2.50k | 10.4% +JP¥6.9b | 374.6% | PS2564.8x | |
| 219A Heartseed | JP¥1.92k | 5.8% +JP¥2.4b | -18.4% | PE74.2x | |
| 2160 GNI Group | JP¥3.18k | 1.1% +JP¥1.9b | 76.0% | PS6.6x |
